Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RANI THERAPEUTICS HOLDINGS, INC.

(RANI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Rani Therapeutics Holdings, Inc. Appoints Talat Imran as Chief Executive Officer

09/13/2021 | 04:05pm EST

Rani Therapeutics Holdings, Inc. announced that In June 2021, the company announced the appointment of Talat Imran as Chief Executive Officer. Mir Imran, Rani’s founder and former Chief Executive Officer, is now serving as Executive Chairman. Talat has been an integral member of Rani’s executive team since 2014, most recently serving as Rani’s Vice President of Strategy. Previously, he also served as Chief Executive Officer of Venture Web Partners, a web application development firm.


© S&P Capital IQ 2021
All news about RANI THERAPEUTICS HOLDINGS, INC.
11/16RANI THERAPEUTICS : Reports Third Quarter 2021 Financial Results, Provides Corporate Updat..
PU
11/16RANI THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Con..
AQ
11/15Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
11/15Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Upda..
GL
11/12RANI THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
11/12Rani Therapeutics Appoints Lyn Baranowski to Board of Directors
AQ
11/12Rani Therapeutics Holdings, Inc. Appoints Lyn Baranowski to Board of Directors
CI
11/10Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthca..
AQ
09/29RANI THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
09/23Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference
GL
More news
Analyst Recommendations on RANI THERAPEUTICS HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 4,44 M - -
Net income 2021 -55,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -28,0x
Yield 2021 -
Capitalization 606 M 606 M -
Capi. / Sales 2021 137x
Capi. / Sales 2022 1 212x
Nbr of Employees 91
Free-Float 9,27%
Chart RANI THERAPEUTICS HOLDINGS, INC.
Duration : Period :
Rani Therapeutics Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RANI THERAPEUTICS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 30,75 $
Average target price 26,60 $
Spread / Average Target -13,5%
EPS Revisions
Managers and Directors
Talat Imran Chief Executive Officer & Director
Svai S. Sanford Chief Financial Officer
Mir A. Imran Executive Chairman
Mir Hashim Chief Scientific Officer
Dennis Arthur Ausiello Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RANI THERAPEUTICS HOLDINGS, INC.0.00%606
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431